Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Nanostructured Lipid Carriers: Design, Properties and Applications in Drug Delivery"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 May 2023 | Viewed by 6557
Special Issue Editors
Interests: lipid carriers; low solubility; pharmaceutical technology; nanocarriers; topical drug delivery; formulation and characterization of dosage forms; drug release; skin permeation
Interests: lipid carriers; pharmaceutical technology; drug formulation; characterization of dosage forms; solubilization techniques; polymers; antimicrobial activity; skin penetration; topical drug delivery
Special Issue Information
Nanostructured lipid carriers (NLCs) are one of the lipid-based nanosystems reported as alternatives to emulsions, liposomes, microparticles and solid lipid nanoparticles (SLNs). NLCs are composed of both solid and liquid lipids as core matrix, usually with biocompatible and biodegradable properties. These nanosystems are widely described by many researchers, and have demonstrated application in many fields, including biomedical, pharmaceutical and cosmetic industries. The most significant advantages of these dosage forms include increased solubility, the protection of labile active substances, enhanced storage stability, improved permeability and bioavailability, and the ability to obtain controlled or targeted release. These benefits make it possible to reduce the frequency of drug administration, limit the risk of adverse effects, and promote patient comfort.
This Special Issue will be a collection of full papers, short communications, and review papers dedicated to the latest advances in nanostructured lipid carriers. Readers will find new information about NLCs, focused on issues such as structure, preparation techniques, characterization, and various applications in drug delivery. Studies offering innovative methodologies and new applications of nanostructured lipid carriers are also welcome.
Dr. Anna Czajkowska-Kośnik
Dr. Magdalena Wróblewska
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- lipid nanocarriers
- drug delivery
- improved drug bioavailability
- formulation and dosage form development
- solubilization technology
- controlled release
- various routes of administration
- synthesis and characterization